About Us
About Us
We are a full-service clinical and pathology laboratory providing high-quality diagnostic testing services for physicians and hospitals.
ABOUT US
A Vision for a Healthier Planet
A Vision for a Healthier Planet
Born as a spin-off from the National University of Singapore, we are on a mission to deliver sustainable, science-driven solutions for a healthier world. Our team of leading scientists and innovators works at the intersection of synthetic biology, precision biomanufacturing, and green technology.
We are a team of passionate scientists with a shared vision: to deliver scalable, sustainable, and science-driven solutions for the world’s most pressing health and environmental challenges. Drawing on deep expertise in engineering biology, bioprocess engineering, and green technology, we combine innovation with impact—creating high-value bioproducts that make a difference.
Singapore’s National Synthetic Biology R&D Programme commissions Research to develop a Synthetic Cannabinoid Biology Programme to deliver life-saving cannabinoids-based therapeutics in a sustainable manner.
Synthetic Cannabinoid Biology: Repurposing Nature for Tomorrow’s Therapeutics led by Associate Professor Yew Wen Shan from NUS SynCTI.
Prof Yew’s research results in the development of proprietary GRAS yeast strains that biomanufacture High-Grade Cannabinoids (HGCs).
He is the first to discover novel enzymatic ways to produce HGCs including market-leading HGCs such as CBD, THC, CBGA and CBC; and potentially market-disruptive HGCs such as CBE, CBT and CBL.
wenSymes Pte Ltd, a Spin-off company of NUS, is formed. Focusing on sustainable solutions for planetary health, wenSymes hold key patents on cannabinoid bioproduction in yeast, production of D-lysergic acid in yeast, and sustainable solutions in food and lifestyle products biomanufacturing using enzymes.
2018
Singapore’s National Synthetic Biology R&D Programme commissions Research to develop a Synthetic Cannabinoid Biology Programme to deliver life-saving cannabinoids-based therapeutics in a sustainable manner.
Synthetic Cannabinoid Biology: Repurposing Nature for Tomorrow’s Therapeutics led by Associate Professor Yew Wen Shan from NUS SynCTI
2020
Prof Yew’s research results in the development of proprietary GRAS yeast strains that biomanufacture High-Grade Cannabinoids (HGCs).
He is the first to discover novel enzymatic ways to produce HGCs including market-leading HGCs such as CBD, THC, CBGA and CBC; and potentially market-disruptive HGCs such as CBE, CBT and CBL.
2022
wenSymes Pte Ltd, a Spin-off company of NUS, is formed. Focusing on sustainable solutions for planetary health, wenSymes hold key patents on cannabinoid bioproduction in yeast, production of D-lysergic acid in yeast, and sustainable solutions in food and lifestyle products biomanufacturing using enzymes.
Why Choose Us?
What We Do
Sustainable Ingredients for a Better World!
1. Innovative Cannabinoids for Wellness
2. Medical Psychedelic Precursors
3. Custom Protein Production & Scale-Up Services
4. Greener Biomanufacturing Solutions
Our Team
Leaders in Science and Innovation
Meet the multidisciplinary experts behind wenSymes. Our team includes renowned scientists, engineers, and business leaders dedicated to advancing biotech for good.
What We Do
Sustainable Ingredients for a Better World!
Innovative Cannabinoids for Wellness
Medical Psychedelic Precursors
Custom Protein Production & Scale-Up Services
Greener Biomanufacturing Solutions
Leaders in Science and Innovation
Our Team
Meet the multidisciplinary experts behind wenSymes. Our team includes renowned scientists, engineers, and business leaders dedicated to advancing biotech for good.
Our Primary Partner
Nullam accumsan lorem in dui cras varius cras non dolor praesent metus.
Phasellus a est donec venenatis vulputate lorem cras risus ipsum, faucibus ut.
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac.
Praesent blandit laoreet nibh. Aenean leo ligula, porttitor eu, consequat vitae.